vs

Side-by-side financial comparison of Nebius Group N.V. (NBIS) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Nebius Group N.V. is the larger business by last-quarter revenue ($32.1M vs $17.3M, roughly 1.9× Sol-Gel Technologies Ltd.).

Nebius Group N.V., headquartered in Amsterdam, is a technology company that provides artificial intelligence infrastructure. The company also owns Avride and TripleTen, as well as stakes in Toloka and Clickhouse. It is headquartered in Amsterdam with offices in Israel and the United States.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

NBIS vs SLGL — Head-to-Head

Bigger by revenue
NBIS
NBIS
1.9× larger
NBIS
$32.1M
$17.3M
SLGL

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
NBIS
NBIS
SLGL
SLGL
Revenue
$32.1M
$17.3M
Net Profit
$11.6M
Gross Margin
Operating Margin
-251.1%
65.1%
Net Margin
67.3%
Revenue YoY
217.7%
Net Profit YoY
487.6%
EPS (diluted)
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NBIS
NBIS
SLGL
SLGL
Q3 25
$32.1M
Q2 25
$24.2M
$17.3M
Q3 24
$79.6M
Q2 24
$36.3M
$5.4M
Q2 23
$594.0K
Q2 22
$3.5M
Net Profit
NBIS
NBIS
SLGL
SLGL
Q3 25
Q2 25
$-185.4M
$11.6M
Q3 24
$-258.2M
Q2 24
$-118.3M
$2.0M
Q2 23
$-6.0M
Q2 22
$-134.0K
Operating Margin
NBIS
NBIS
SLGL
SLGL
Q3 25
-251.1%
Q2 25
-754.1%
65.1%
Q3 24
-366.1%
Q2 24
-563.1%
29.9%
Q2 23
-1098.8%
Q2 22
-13.2%
Net Margin
NBIS
NBIS
SLGL
SLGL
Q3 25
Q2 25
-766.1%
67.3%
Q3 24
-324.4%
Q2 24
-325.9%
36.4%
Q2 23
-1005.1%
Q2 22
-3.8%
EPS (diluted)
NBIS
NBIS
SLGL
SLGL
Q3 25
Q2 25
$4.17
Q3 24
Q2 24
$0.71
Q2 23
$-0.22
Q2 22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NBIS
NBIS
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$4.8B
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.8B
$31.9M
Total Assets
$10.1B
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NBIS
NBIS
SLGL
SLGL
Q3 25
$4.8B
Q2 25
$1.7B
$24.3M
Q3 24
$2.3B
Q2 24
$2.3B
$26.5M
Q2 23
$33.5M
Q2 22
$15.6M
Stockholders' Equity
NBIS
NBIS
SLGL
SLGL
Q3 25
$4.8B
Q2 25
$3.8B
$31.9M
Q3 24
$2.9B
Q2 24
$4.3B
$34.9M
Q2 23
$48.3M
Q2 22
$50.4M
Total Assets
NBIS
NBIS
SLGL
SLGL
Q3 25
$10.1B
Q2 25
$5.1B
$39.3M
Q3 24
$3.0B
Q2 24
$4.4B
$42.0M
Q2 23
$55.1M
Q2 22
$55.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NBIS
NBIS
SLGL
SLGL
Operating Cash FlowLast quarter
$-196.8M
Free Cash FlowOCF − Capex
$-586.8M
FCF MarginFCF / Revenue
-1828.0%
Capex IntensityCapex / Revenue
1215.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NBIS
NBIS
SLGL
SLGL
Q3 25
$-196.8M
Q2 25
$-162.0M
Q3 24
Q2 24
Q2 23
$-8.3M
Q2 22
Free Cash Flow
NBIS
NBIS
SLGL
SLGL
Q3 25
$-586.8M
Q2 25
$-379.9M
Q3 24
Q2 24
Q2 23
$-8.4M
Q2 22
FCF Margin
NBIS
NBIS
SLGL
SLGL
Q3 25
-1828.0%
Q2 25
-1569.8%
Q3 24
Q2 24
Q2 23
-1419.0%
Q2 22
Capex Intensity
NBIS
NBIS
SLGL
SLGL
Q3 25
1215.0%
Q2 25
900.4%
Q3 24
Q2 24
Q2 23
15.8%
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NBIS
NBIS

Nebius$27.1M84%
TripleTen$6.3M20%
Avride$100.0K0%

SLGL
SLGL

Segment breakdown not available.

Related Comparisons